One of the greatest challenges in drug development remains the difficulty in choosing tractable biological targets and investing sufficient financial and human resources in the exploration of un-validated disease areas to bring a new therapeutic to market approval. Like any scientific endeavor, most programs provide some beneficial guidance but ultimately fail to make it to the ultimate goal – in drug discovery, this is as an FDA approved medicine. The high rate of clinical failure has required most companies to invest over $850 million for each drug that reaches the market, and often 12 years or more time along the way. Auspex has a better approach.

3366 N. Torrey Pines Ct. Suite 225   La Jolla, CA 92037   858-558-2400 phone   858-558-2401 fax

Auspex Pharmaceuticals is a pioneer in the development of deuterated analogs of clinically-validated drugs, applying this strategy to existing drugs across multiple therapeutic areas.